Autres langues Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Produits pharmaceutiques

Marché Fermé - Sao Paulo 20:29:29 28/08/2026			Varia. 5j.	Varia. 1 janv.
80,39 ^BRL	-0,38%		-0,38%	+21,88%

27/08	Les actions britanniques reculent face aux tensions mondiales ; AstraZeneca en baisse	MT
27/08	Les bourses européennes clôturent majoritairement en baisse jeudi, dans l'attente du discours du président de la Fed	MT

Autres langues

28/08	AstraZeneca - Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
27/08	UK Shares Fall as Global Tensions Mount; AstraZeneca Drops
27/08	European Stocks Close Mostly Lower in Thursday Trading as Investors Await Fed Chair Speech
27/08	Global markets live: Apple, Meta, Nvidia, Salesforce, KKR…
27/08	AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients
27/08	AstraZeneca and Amgen announce positive Tezspire trial results in EoE
27/08	Astrazeneca-Medikament Tezspire erreicht Studienziel bei Ösophagitis
27/08	Amgen and AstraZeneca Demonstrate Positive Phase 3 Results For Tezspire In Eosinophilic Esophagitis
27/08	PPHE Hotel Group swings to half-year profit
27/08	AstraZeneca, Amgen's Tezspire Improves Eosinophilic Esophagitis Symptoms in Late-stage Trial
27/08	AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial
27/08	AstraZeneca's asthma drug Tezspire meets all goals in late-stage esophagitis trial
27/08	TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
27/08	UK Stocks-Factors to watch on August 27
21/08	FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case
18/08	TScan Therapeutics, Inc. And Amgen Inc. Terminate Research Collaboration And License Agreement
18/08	GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
18/08	CSL's Share Price Hits Six-Month High on Guidance Beat
17/08	Sandoz: diritti commerciali su alcuni biosimilari cinesi
17/08	Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech
14/08	Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing
11/08	Global drugmakers invest billions to boost US presence
10/08	Amgen Insider Sold Shares Worth $1,194,416, According to a Recent SEC Filing
10/08	Amgen Insider Sold Shares Worth $1,565,898, According to a Recent SEC Filing
06/08	Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq